Article: Essential, Fujisawa Team Up In Antibiotics Discovery Effort.

Staff Writer

In an effort to develop new antibiotics, Essential Therapeutics Inc. entered into a collaborative agreement with Fujisawa Pharmaceutical Co. Ltd.

Essential will use its technology to develop assay systems for the discovery of antibiotics, and will perform high-throughput screening of compounds in Fujisawa's library.

"It's the core expertise in antibiotics and anti-infectives that we've been known for since 1992 that they found appealing," said Nancy Wetherbee, Essential's vice president of business development. "Our technology portfolio is quite broad, but Fujisawa does not want us to release this particular technology that was ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!